share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Borgeson Blake
美股sec公告 ·  07/11 16:54
Moomoo AI 已提取核心訊息
On July 9, 2024, Blake Borgeson, a key figure at Recursion Pharmaceuticals, completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was carried out on the open market at a price of $7.315 per share, resulting in a total sale value of approximately $83,734.81. Following this transaction, Borgeson's direct holdings in Recursion Pharmaceuticals amount to 7,167,110 shares. The sale reflects a transaction within the normal course of trading and does not necessarily indicate a shift in the company's long-term prospects.
On July 9, 2024, Blake Borgeson, a key figure at Recursion Pharmaceuticals, completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was carried out on the open market at a price of $7.315 per share, resulting in a total sale value of approximately $83,734.81. Following this transaction, Borgeson's direct holdings in Recursion Pharmaceuticals amount to 7,167,110 shares. The sale reflects a transaction within the normal course of trading and does not necessarily indicate a shift in the company's long-term prospects.
2024年7月9日，Recursion Pharmaceuticals重要人物布雷克·博傑森以每股7.315美元的價格在公開市場上完成了對該公司A類普通股的11,447股出售，總銷售價值約爲83,734.81美元。在此次交易之後，博傑森在Recursion Pharmaceuticals的直接持股爲7,167,110股。此次出售反映了公司正常交易過程中的一項交易，不一定意味着該公司的長期前景發生了變化。
2024年7月9日，Recursion Pharmaceuticals重要人物布雷克·博傑森以每股7.315美元的價格在公開市場上完成了對該公司A類普通股的11,447股出售，總銷售價值約爲83,734.81美元。在此次交易之後，博傑森在Recursion Pharmaceuticals的直接持股爲7,167,110股。此次出售反映了公司正常交易過程中的一項交易，不一定意味着該公司的長期前景發生了變化。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息